The Experts below are selected from a list of 297 Experts worldwide ranked by ideXlab platform
Yang Hyeon Jeon - One of the best experts on this subject based on the ideXlab platform.
-
Acetic acid as a Sclerosing Agent for renal cysts: Comparison with ethanol in follow-up results
CardioVascular and Interventional Radiology, 2000Co-Authors: Joo Hyeong Oh, Yup Yoon, Seong Jin Park, Sung-goo Chang, Yang Hyeon JeonAbstract:Purpose: To compare follow-up results of sclerotherapy for renal cyst using 50% acetic acid with those using 99% ethanol as Sclerosing Agents. Methods: Eighty-one patients underwent sclerotherapy and 58 patients, 23 males, 35 females, aged 6–76 years, having a total of 60 cysts, were included in this study; the others were lost to follow-up. The renal cysts were diagnosed by sonography, computed tomography (CT), or magnetic resonance imaging (MRI). Sclerotherapy was performed using 50% acetic acid for 32 cysts in 3 1 patients and 99% ethanol for 28 cysts in 27 patients. Under fluoroscopic guidance, cystic fluid was aspirated as completely as possible. After instillation of a Sclerosing Agent corresponding to 1 1.7%–25% (4–100 ml) of the aspirated volume, the patient changed position for 20 min and then the Agent was removed. Patients were followed up by sonography for a period of 1–49 months. The volume of the renal cyst after sclerotherapy was compared with that of the renal cyst calculated before sclerotherapy. Medical records were reviewed to analyze complications. Results: The mean volume after sclerotherapy of the 17 cysts followed for 3–4 months in the acetic acid group was 5.1% of the initial volume, and for the 14 cysts in the ethanol group it was 10.2%. Complete regression during follow-up was shown in 21 cysts (66%) in the acetic acid group; the mean volume of these cysts before the procedure was 245 ml. The mean volume of the nine (32%) completely regressed cysts in the ethanol group was 184 ml. Mild flank pain, which occurred in three patients in each group, was the only complication and resolved the next day. Conclusion: Acetic acid was an effective and safe Sclerosing Agent for renal cysts, tending to induce faster and more complete regression than ethanol.
-
acetic acid as a Sclerosing Agent for renal cysts comparison with ethanol in follow up results
CardioVascular and Interventional Radiology, 2000Co-Authors: Joo Hyeong Oh, Yup Yoon, Seong Jin Park, Sung-goo Chang, Yang Hyeon JeonAbstract:Purpose: To compare follow-up results of sclerotherapy for renal cyst using 50% acetic acid with those using 99% ethanol as Sclerosing Agents.
Joo Hyeong Oh - One of the best experts on this subject based on the ideXlab platform.
-
Acetic acid as a Sclerosing Agent for renal cysts: Comparison with ethanol in follow-up results
CardioVascular and Interventional Radiology, 2000Co-Authors: Joo Hyeong Oh, Yup Yoon, Seong Jin Park, Sung-goo Chang, Yang Hyeon JeonAbstract:Purpose: To compare follow-up results of sclerotherapy for renal cyst using 50% acetic acid with those using 99% ethanol as Sclerosing Agents. Methods: Eighty-one patients underwent sclerotherapy and 58 patients, 23 males, 35 females, aged 6–76 years, having a total of 60 cysts, were included in this study; the others were lost to follow-up. The renal cysts were diagnosed by sonography, computed tomography (CT), or magnetic resonance imaging (MRI). Sclerotherapy was performed using 50% acetic acid for 32 cysts in 3 1 patients and 99% ethanol for 28 cysts in 27 patients. Under fluoroscopic guidance, cystic fluid was aspirated as completely as possible. After instillation of a Sclerosing Agent corresponding to 1 1.7%–25% (4–100 ml) of the aspirated volume, the patient changed position for 20 min and then the Agent was removed. Patients were followed up by sonography for a period of 1–49 months. The volume of the renal cyst after sclerotherapy was compared with that of the renal cyst calculated before sclerotherapy. Medical records were reviewed to analyze complications. Results: The mean volume after sclerotherapy of the 17 cysts followed for 3–4 months in the acetic acid group was 5.1% of the initial volume, and for the 14 cysts in the ethanol group it was 10.2%. Complete regression during follow-up was shown in 21 cysts (66%) in the acetic acid group; the mean volume of these cysts before the procedure was 245 ml. The mean volume of the nine (32%) completely regressed cysts in the ethanol group was 184 ml. Mild flank pain, which occurred in three patients in each group, was the only complication and resolved the next day. Conclusion: Acetic acid was an effective and safe Sclerosing Agent for renal cysts, tending to induce faster and more complete regression than ethanol.
-
acetic acid as a Sclerosing Agent for renal cysts comparison with ethanol in follow up results
CardioVascular and Interventional Radiology, 2000Co-Authors: Joo Hyeong Oh, Yup Yoon, Seong Jin Park, Sung-goo Chang, Yang Hyeon JeonAbstract:Purpose: To compare follow-up results of sclerotherapy for renal cyst using 50% acetic acid with those using 99% ethanol as Sclerosing Agents.
Sami Arap - One of the best experts on this subject based on the ideXlab platform.
-
treatment of simple renal cysts with single session percutaneous ethanol sclerotherapy without drainage of the Sclerosing Agent
The Journal of Urology, 2004Co-Authors: Renato Falcijunior, Antonio Marmo Lucon, Luciana Mendes De Oliveira Cerri, Alexandre Danilovic, Paula Dias C Da Rocha, Sami ArapAbstract:Purpose: To evaluate percutaneous single-session sclerotherapy with ethanol without drainage of the Sclerosing Agent in symptomatic simple renal cysts that require treatment. Patients and Methods: A prospective series of 30 consecutive patients with symptomatic simple renal cysts with volume of 280.3 ± 365.23 mL (range 28–1700 mL) estimated by ultrasonography were treated between July 1999 and July 2003. The cysts were punctured with an 18-gauge, 20-cm needle under ultrasound guidance and local anesthesia. A volume of ethanol equivalent to one third of the aspirated volume, up to a maximum of 100 mL, was injected into the cyst and left there. The patients were reassessed at 1, 3, and 6 months. Results: The procedure was technically feasible in all patients. The aspirated volume was 259.8 ± 265.2 mL (range 30–1900 mL). After 1, 3, and 6 months, the average volume was 52.7 ± 71.4 mL, 22.7 ± 43.2 mL, and 11.6 ± 30.7 mL, respectively. After this period, 28 patients (93%) were asymptomatic, showing total remis...
Sung-goo Chang - One of the best experts on this subject based on the ideXlab platform.
-
Acetic acid as a Sclerosing Agent for renal cysts: Comparison with ethanol in follow-up results
CardioVascular and Interventional Radiology, 2000Co-Authors: Joo Hyeong Oh, Yup Yoon, Seong Jin Park, Sung-goo Chang, Yang Hyeon JeonAbstract:Purpose: To compare follow-up results of sclerotherapy for renal cyst using 50% acetic acid with those using 99% ethanol as Sclerosing Agents. Methods: Eighty-one patients underwent sclerotherapy and 58 patients, 23 males, 35 females, aged 6–76 years, having a total of 60 cysts, were included in this study; the others were lost to follow-up. The renal cysts were diagnosed by sonography, computed tomography (CT), or magnetic resonance imaging (MRI). Sclerotherapy was performed using 50% acetic acid for 32 cysts in 3 1 patients and 99% ethanol for 28 cysts in 27 patients. Under fluoroscopic guidance, cystic fluid was aspirated as completely as possible. After instillation of a Sclerosing Agent corresponding to 1 1.7%–25% (4–100 ml) of the aspirated volume, the patient changed position for 20 min and then the Agent was removed. Patients were followed up by sonography for a period of 1–49 months. The volume of the renal cyst after sclerotherapy was compared with that of the renal cyst calculated before sclerotherapy. Medical records were reviewed to analyze complications. Results: The mean volume after sclerotherapy of the 17 cysts followed for 3–4 months in the acetic acid group was 5.1% of the initial volume, and for the 14 cysts in the ethanol group it was 10.2%. Complete regression during follow-up was shown in 21 cysts (66%) in the acetic acid group; the mean volume of these cysts before the procedure was 245 ml. The mean volume of the nine (32%) completely regressed cysts in the ethanol group was 184 ml. Mild flank pain, which occurred in three patients in each group, was the only complication and resolved the next day. Conclusion: Acetic acid was an effective and safe Sclerosing Agent for renal cysts, tending to induce faster and more complete regression than ethanol.
-
acetic acid as a Sclerosing Agent for renal cysts comparison with ethanol in follow up results
CardioVascular and Interventional Radiology, 2000Co-Authors: Joo Hyeong Oh, Yup Yoon, Seong Jin Park, Sung-goo Chang, Yang Hyeon JeonAbstract:Purpose: To compare follow-up results of sclerotherapy for renal cyst using 50% acetic acid with those using 99% ethanol as Sclerosing Agents.
Seong Jin Park - One of the best experts on this subject based on the ideXlab platform.
-
Acetic acid as a Sclerosing Agent for renal cysts: Comparison with ethanol in follow-up results
CardioVascular and Interventional Radiology, 2000Co-Authors: Joo Hyeong Oh, Yup Yoon, Seong Jin Park, Sung-goo Chang, Yang Hyeon JeonAbstract:Purpose: To compare follow-up results of sclerotherapy for renal cyst using 50% acetic acid with those using 99% ethanol as Sclerosing Agents. Methods: Eighty-one patients underwent sclerotherapy and 58 patients, 23 males, 35 females, aged 6–76 years, having a total of 60 cysts, were included in this study; the others were lost to follow-up. The renal cysts were diagnosed by sonography, computed tomography (CT), or magnetic resonance imaging (MRI). Sclerotherapy was performed using 50% acetic acid for 32 cysts in 3 1 patients and 99% ethanol for 28 cysts in 27 patients. Under fluoroscopic guidance, cystic fluid was aspirated as completely as possible. After instillation of a Sclerosing Agent corresponding to 1 1.7%–25% (4–100 ml) of the aspirated volume, the patient changed position for 20 min and then the Agent was removed. Patients were followed up by sonography for a period of 1–49 months. The volume of the renal cyst after sclerotherapy was compared with that of the renal cyst calculated before sclerotherapy. Medical records were reviewed to analyze complications. Results: The mean volume after sclerotherapy of the 17 cysts followed for 3–4 months in the acetic acid group was 5.1% of the initial volume, and for the 14 cysts in the ethanol group it was 10.2%. Complete regression during follow-up was shown in 21 cysts (66%) in the acetic acid group; the mean volume of these cysts before the procedure was 245 ml. The mean volume of the nine (32%) completely regressed cysts in the ethanol group was 184 ml. Mild flank pain, which occurred in three patients in each group, was the only complication and resolved the next day. Conclusion: Acetic acid was an effective and safe Sclerosing Agent for renal cysts, tending to induce faster and more complete regression than ethanol.
-
acetic acid as a Sclerosing Agent for renal cysts comparison with ethanol in follow up results
CardioVascular and Interventional Radiology, 2000Co-Authors: Joo Hyeong Oh, Yup Yoon, Seong Jin Park, Sung-goo Chang, Yang Hyeon JeonAbstract:Purpose: To compare follow-up results of sclerotherapy for renal cyst using 50% acetic acid with those using 99% ethanol as Sclerosing Agents.